Our projects
Targeting mitochondria to revolutionize medical treatments
From a laboratory at the University of Geneva, MPC Therapeutics harnesses the potential of mitochondria to revolutionize medical treatments.
Behind the scenes of Cortexia's development: support from Alliance and platinn
The life of a company is made up of numerous challenges that often have to be met simultaneously. The mission of the Alliance and platinn coaching services is to help companies in Western Switzerland meet these challenges. Demonstration with Cortexia, which was coached by both entities between 2018 and 2023.
A digital twin for biocomposite optimization
In 2019, Dynatec, a company with expertise in high-precision machining, has embarked on an ambitious project: to develop a biobased composite material and combine it with a digital twin to optimize the implementation process and thus gain in agility. The project was carried out in collaboration with HEIG-VD, and received Innosuisse funding with the help of Alliance.
Aspivix, a gynaecological instrument that respects women's privacy
For over a century, most women have suffered from gynecological procedures performed with Pozzi forceps. Equipped with claws, these forceps too often cause severe pain. That's why Aspivix, a Vaud-based start-up, has developed an alternative that respects women's intimacy and is less painful, based on the suction cup principle.
HemostOD: platelets on demand
HemostOD, an EPFL start-up supported by Alliance to obtain an Innosuisse grant, has developed an innovative solution for producing platelets ex vivo, enabling large quantities to be generated in a short space of time.
Limula, the company revolutionizing cancer cell therapy
Lausanne-based Limula is revolutionizing cancer cell and gene therapy by simplifying the manufacturing process, thanks to an innovative bioreactor that enables these highly personalized treatments to be produced at scale and on demand.